Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Lenalidomide for Patients With Myelofibrosis (MF)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2